Anzeige
Meldung des Tages: „Echte Revolution“: Dieses MedTech-Unternehmen greift nach dem Milliardenmarkt

OREXO Aktie News

Aktie
WKN:  ISIN:  US68616W1027 US-Symbol:  ORXOY
2,60 $
-0,4 $
-13,33%
2,2038 € 17.12.25
Depot/Watchlist
Marktkapitalisierung *
-
Streubesitz
-
KGV
-
Index-Zuordnung
-

OREXO News

05.09.25 - PR Newswire
Orexo's AmorphOX technology may pave the way for intranasal GLP-1 medication
Orexo's AmorphOX technology may pave the way for intranasal GLP-1 medication PR Newswire
05.09.25 - PR Newswire
Orexo's AmorphOX technology may pave the way for intranasal GLP-1 medication
Orexo's AmorphOX technology may pave the way for intranasal GLP-1 medication PR Newswire
02.06.25 - PR Newswire
Orexo to present clinical data for OX640 at the EAACI Congress
Orexo to present clinical data for OX640 at the EAACI Congress PR Newswire
02.06.25 - PR Newswire
Orexo to present clinical data for OX640 at the EAACI Congress
Orexo to present clinical data for OX640 at the EAACI Congress PR Newswire
10.04.25 - PR Newswire
Orexo announces positive data for powder-based intranasal vaccine formulated with the AmorphOX technology
Orexo announces positive data for powder-​based intranasal vaccine formulated with the AmorphOX technology PR Newswire
10.04.25 - PR Newswire
Orexo announces positive data for powder-based intranasal vaccine formulated with the AmorphOX technology
Orexo announces positive data for powder-​based intranasal vaccine formulated with the AmorphOX technology PR Newswire
10.01.25 - PR Newswire
Orexo announces positive topline data from clinical study of OX640 in subjects with and without allergic rhinitis
Orexo announces positive topline data from clinical study of OX640 in subjects with and without allergic rhinitis PR Newswire
10.01.25 - PR Newswire
Orexo announces positive topline data from clinical study of OX640 in subjects with and without allergic rhinitis
Orexo announces positive topline data from clinical study of OX640 in subjects with and without allergic rhinitis PR Newswire

Newssuche

Videos

newspaper
16.12.25 +1,32%
Technical Trading: DAX Setup mit Kurzfrist Trade
DAX Long Typ: Turbo Open End WKN: VK2CGA Hebel:11,30 Laufzeit: OpenEnd Einstieg: Market ... Mehr »
Anzeige

Aktie im Fokus

Kein Weihnachtswunder
DiagnosTear Technologies Inc
0,352 €
-3,83%
DiagnosTear Technologies Inc Chart
Blutuntersuchung ohne Blutabnahme!
Mehr zur Aktie »